Danusertib

• Description:

  A potent, ATP-competitive Aurora kinase inhibitor with IC50 of 13,79 and 61 nM for Aurora A, B and C, respectively; Also inhibits Abl, RET, and FGFR1 (IC50=25,31, and 47 nM) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  474.5548

• Molecular Formula:

  C26H30N6O3

• Notes:

  Research use only, not for human use.

• Receptor:

  Abl|AuroraA|AuroraB|AuroraC|FGFR1|RET|TrkA

• CAS Number:

  827318-97-8